Abstract
Purpose
The aim of the present study was to assess the efficacy of a thrombin-based topical haemostatic in reducing blood requirements after total knee replacement (TKR) revision surgery.
Methods
This prospective, randomized, controlled study was designed to evaluate the haemostatic efficacy and safety of a thrombin-based topical haemostatic (Floseal) versus standard treatment in patients receiving total knee revision arthroplasty. The decrease in haemoglobin values postsurgery and the blood units transfused were recorded. The decision to transfuse was made by a surgeon blinded to the patient’s group allocation.
Results
Forty-eight patients were enroled in the study; twenty-four patients each were randomized to the treatment and control groups, respectively. The median decrease in haemoglobin concentration on the first postoperative day was 2.2 g/dL in the treatment group and 2.7 g/dL in the control group. A significant reduction in units of blood transfused was also observed in the treatment group compared with the control group [1.1 ± 1.13 (range 0–4) vs. 1.9 ± 1.41 (range 0–5) blood units; P = 0.04]. No major treatment-related adverse events were recorded in the study.
Conclusions
This study shows that a thrombin-based topical haemostatic reduces the need for blood transfusion in TKR revision surgery.
Clinical relevance
A thrombin-based topical haemostatic agent can be an appropriate solution to enhance haemostasis and vessel sealing at the operative site in TKR revision surgery, in order to reduce the need for blood transfusion after surgery.
Level of evidence
II.
Similar content being viewed by others
References
Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 93(12):1577–1585
Baxter Healthcare Corporation Floseal® Hemostatic Matrix, 10 mL: instructions for use. Available at URL: http://www.baxter.com/downloads/healthcare_professionals/products/Floseal10ml_IFU_r3.pdf
Berman AT, Geissele AE, Bosacco SJ (1988) Blood loss with total knee arthroplasty. Clin Orthop Relat Res 234:137–138
Callaghan JJ, Spitzer AI (2000) Blood management and patient specific transfusion options in total joint replacement surgery. Iowa Orthop J 20:36–45
Clapp B, Santillan A (2011) Small bowel obstruction after FloSeal use. J Soc Laparoendosc Surg 15(3):361–364
Comadoll JL, Comadoll S, Hutchcraft A, Krishnan S, Farrell K, Kreuwel HT, Bechter M (2012) Comparison of hemostatic matrix and standard hemostasis in patients undergoing primary TKA. Orthopedics 35(6):e785–e793
Courtney J, Liebelt D, Nett MP, Cushner FD (2012) Blood loss and transfusion rates following patellofemoral arthroplasty. Orthop Clin North Am 43(5):e44–e47
Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M (2006) Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 46(7):1112–1119
Di Francesco A, Flamini S, Fiori F, Mastri F (2013) Hemostatic matrix effects on blood loss after total knee arthroplasty: a randomized controlled trial. Indian J Orthop 47(5):474–481
Everts PA, Devilee RJ, Oosterbos CJ, Mahoney CB, Schattenkerk ME, Knape JT, van Zundert A (2007) Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 15(7):888–894
Juelsgaard P, Larsen UT, Sorensen JV, Madsen F, Soballe K (2001) Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med 26(2):105–110
Kim HJ, Fraser MR, Kahn B, Lyman S, Figgie MP (2012) The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 94(13):1160–1165
Kluba T, Fiedler K, Kunze B, Ipach I, Suckel A (2012) Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch Orthop Trauma Surg 132(8):1147–1152
Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89(4):780–785
Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gomez-Barrena E, de Pina Mde F, Manno V, Torre M, Walter WL, de Steiger R, Geesink RG, Peltola M, Roder C (2011) International survey of primary and revision total knee replacement. Int Orthop 35(12):1783–1789
Lavernia C, Lee DJ, Hernandez VH (2006) The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res 446:221–226
Liebelt DA, Levy BJ, Kadimcherla PK, Krystal JD, Li R, Lall A, Blum YC, Hirsh DM, Kim SJL (2013) Effects of intraoperative use of the topical hemostatic matrix agent Floseal, in primary unilateral total knee arthroplasty. Curr Orthop Pract 24(5):509–512
Manifold SG, Cushner FD, Craig-Scott S, Scott WN (2000) Long-term results of total knee arthroplasty after the use of soft tissue expanders. Clin Orthop Relat Res 380:133–139
Massin P, Scemama C, Jeanrot C, Boyer P (2012) Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study. OTSR 98(2):180–185
Mesa-Ramos F, Mesa-Ramos M, Maquieira-Canosa C, Carpintero P (2008) Predictors for blood transfusion following total knee arthroplasty: a prospective randomised study. Acta Orthop Belg 74(1):83–89
Mozet C, Prettin C, Dietze M, Fickweiler U, Dietz A (2012) Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol 269(10):2247–2254
Murphy MF, Wallington TB, Kelsey P, Boulton F, Bruce M, Cohen H, Duguid J, Knowles SM, Poole G, Williamson LM (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol 113(1):24–31
Nasso G, Piancone F, Bonifazi R, Romano V, Visicchio G, De Filippo CM, Impiombato B, Fiore F, Bartolomucci F, Alessandrini F, Speziale G (2009) Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 88(5):1520–1526
Notarnicola A, Moretti L, Martucci A, Spinarelli A, Tafuri S, Pesce V, Moretti B (2012) Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 23(4):278–284
Ong KL, Mowat FS, Chan N, Lau E, Halpern MT, Kurtz SM (2006) Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res 446:22–28
Parker MJ, Livingstone V, Clifton R, McKee A (2007) Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev 3: CD001825
Renkens KL Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, Lawson KJ, Lentz R, Shuey H Jr, Conaway GL, Andersson GB, An HS, Hickey M, Rondinone JF, Shargill NS (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 26(15):1645–1650
Sabatini L, Trecci A, Imarisio D, Uslenghi MD, Bianco G, Scagnelli R (2012) Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 13(3):145–151
Seo JG, Moon YW, Park SH, Kim SM, Ko KR (2013) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(8):1869–187430
Spence RK (1998) Anemia in the patient undergoing surgery and the transfusion decision. A review. Clin Orthop Relat Res 357:19–29
Weaver FA, Hood DB, Zatina M, Messina L, Badduke B (2002) Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16(3):286–293
Wille AH, Johannsen M, Miller K, Deger S (2009) Laparoscopic partial nephrectomy using FloSeal for hemostasis: technique and experiences in 102 patients. Surg Innov 16(4):306–312
Acknowledgments
The authors would like to thank Simone Boniface and Sheridan Henness of in Science Communications, Springer Healthcare, who provided medical writing assistance. This assistance was funded by Baxter (Italy). The study was partially funded by the Italian Ministry of Health, Research Project # 4077/2011. CLR is serving as the President of the European Bone and Joint Infection Society and act as scientific project coordinator within the Research Orthopaedic Institute Galeazzi in Milan, Italy.
Conflict of interest
None of the authors has any conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Romanò, C.L., Monti, L., Logoluso, N. et al. Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial. Knee Surg Sports Traumatol Arthrosc 23, 3337–3342 (2015). https://doi.org/10.1007/s00167-014-3153-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-014-3153-8